Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
i-JOURNEY: Portuguese data from an electronic survey regarding HFpEF
Session:
Painel 1 - Insuficiência Cardíaca 7
Speaker:
Luís Mendanha
Congress:
CPC 2020
Topic:
D. Heart Failure
Theme:
10. Chronic Heart Failure
Subtheme:
10.6 Chronic Heart Failure - Clinical
Session Type:
Posters
FP Number:
---
Authors:
Luís Mendanha; Raquel Martins; Daniel Filipe Pinheiro Brás; Margarida Mateus; Marisa Pardal; Ana Magalhães Martins
Abstract
<p><strong>Background: </strong>Data regarding how Portuguese clinicians diagnose, treat and follow-up patients with heart failure with preserved ejection fraction (HFpEF) are lacking. <strong>Objective: </strong>This survey aimed to obtain exploratory data about Portuguese clinicians perceptions regarding HFpEF. <strong>Methods: </strong>A structured electronic survey (i-JOURNEY) was answered by medical specialists that follow-up HFpEF patients in Portugal. <strong>Results: </strong>Eighty nine Portuguese clinicians answered the survey: 50.6% cardiologists, 41.6% internists, 6.7% general practitioners and 1.1% from other specialties. <u>Diagnosis:</u> 34.9% clinicians estimated that more than 50% of the total patients with HF had HFpEF and more than half reported that more that 40% of patients with HFpEF were diagnosed by themselves. Diagnosis was performed based on signs and symptoms by 97.9% of clinicians, whereas echocardiogram and biomarkers were used by 95.3% and 81.4% of respondents. In most cases, HFpEF was diagnosed following an acute decompensation (54.7%), during a hospitalization (50%) or due to persistent signs and symptoms (47.7%). The main suspicious symptoms were dyspnea (81.4%), fatigue (68.6%), orthopnea and paroxysmal nocturnal dyspnea (both 64.0%) and edema (59.3%). The most common comorbidities of patients with HFpEF were hypertension (97.7%), diabetes mellitus (93%), atrial fibrillation (96.5%), obesity (68.6%), and renal chronic disease (72.1%). <u>Treatment:</u> Relief of signs and symptoms (86%), avoidance of acute decompensation/hospitalization (86%), and improvement of quality of life (83.7%) were the main goals for HFpEF treatment. Risk factors associated with worse prognosis were lower glomerular filtration rate (76.5%), advanced age (68.2%), and high levels of BNP/NTproBNP (62.4%). <u>Follow-up:</u> Only 8.2% of clinicians see their HFpEF patients more than 5 times/year while 41.3% see their patients 3 times/year. Only 20% of clinicians reported their Institution had an integrated plan of discharge for patients with HFpEF. Finally, after hospital discharge, 23.5% of clinicians follow-up their patients in the first two weeks and 4.7% after more than 90 days. The remaining clinicians follow-up their patients between 15 and 90 days.</p> <p><strong>Conclusion: </strong>This exploratory analysis shows that there are several unmet needs, both in diagnosis and monitoring of Portuguese patients with HFpEF that need to be addressed for a better management and outcomes of these patients.</p> <p> </p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site